ORLANDO, Fla. – PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the launch of the Jade DSC, the latest in PerkinElmer’s Thermal Analysis line of DSC’s, at PITTCON® 2006, Booth 2669.  Building on the proven Pyris 6 DSC platform, the Jade DSC is more flexible, offering new features to expand the application capabilities for routine applications, QA/QC and education.

Incorporating input from users around the world, new capabilities extend the application and operating convenience of the Jade DSC.  A liquid nitrogen cooling system automates low temperature testing for more complete characterization of rubber and elastomers.  Improved baseline flatness and stability assures accurate measurement of typical thermal events in the polymer, pharmaceutical, chemical and food industries.  For the busy QA/QC laboratory, advances in autosampler control result in higher sample throughput and improved productivity.

“As the premier supplier of thermal analysis solutions for laboratories worldwide, PerkinElmer works in close cooperation with our customers to provide the highest quality lab experience,” said Jonathan Rennert, vice president and general manager, Analytical Sciences, for PerkinElmer’s Life and Analytical Sciences division. “The new Jade DSC continues PerkinElmer’s tradition of offering reliable best-in-class thermal analysis products delivering accurate data along with enhanced flexibility. Whether you work in a research laboratory or a QA/QC lab, the Jade DSC provides world class performance.”

The Jade DSC offers several key features for improved performance and enhanced flexibility, including:

• Autosampler option for higher throughput and unattended operation – The Jade DSC’s 45-position autosampler option and unique carousel design improve productivity and ensure reproducible results in the temperature range from -180°C to + 450 ºC.

• Convenient automated liquid nitrogen cooling option to -180°C – The Jade DSC enables users to configure their equipment to meet the needs of their laboratory by providing a variety of cooling devices, including the option of an automated low consumption liquid nitrogen cooling system which provides measurements from temperatures as low as -180°C.  

• Portable cooling device (PCD) for cost-effective low temperature operation – A portable cooling device can be used in combination with the standard Jade DSC configuration to quickly cool to ambient temperature or to cool below room temperature for occasional subambient measurements, without any instrument modification.

• Integrated mass flow controller for precise gas control and gas switching – The Jade DSC features a built-in mass flow controller to monitor and control purge gas flow rates, automatically adjusting the rate to match the needs of a specific application. The controller also allows switching between any two gases, such as programmed switching between inert and oxidizing (or reducing) gas types.

For more information on PerkinElmer’s Jade DSC, please visit: www.perkinelmer.com/jadedsc.

Factors Affecting Future Performance

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements.  Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct.  A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements.  These factors include, without limitation: (1) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (2) risks related to our failure to introduce new products in a timely manner; (3) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (4) a delay in resolution of the Company’s tax audits and an adverse determination with respect to the Company’s tax audits by the Internal Revenue Service or other taxing authorities; (5) cyclical downturns continuing to affect several of the industries into which we sell our products; (6) our ability to adjust our operations to address unexpected changes; (7) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (8) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (9) competition; (10) regulatory compliance; (11) regulatory changes; (12) our failure to obtain and enforce intellectual property protection; (13) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (14) other factors which we describe under the caption “Forward-Looking Information and Factors Affecting Future Performance” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings  with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information

Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging.  Photonics markets include sensors and specialty lighting.